COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
ILC Therapeutics is a UK biotech developing synthetic "hybrid" interferons and peptide therapeutics to modulate innate immunity, advancing inhaled lead candidate Alfacyte for respiratory viral infections toward clinical trials.
